Search

BIOLAN launches a new analytical solution that allows to quantitatively classify the degree of YAKE in tuna, without the need to defrost and generate damage in the piece, and digitally monitor its

ZeClinics has recently started a new collaboration with the Institut de la Vision, led by Filippo del Bene, to test in zebrafish the most cutting-edge genetic modification technologies

ZeClinics and Dompé Farmaceutici started this collaboration a few years ago, in an effort to validate the use of zebrafish to reliably model human retinopathies and, most importantly, to test

GMP is the highest quality seal that certifies that the Spanish biotechnology company complies with the Good Manufacturing Practices for the manufacture of pharmaceutical products in the European

BO-112 demonstrates potential as new and highly effective second line therapy for melanoma

Almirall recently announced collaboration agreements with the University of Michigan to accelerate the understanding of the factors that trigger hidradenitis suppurativa

BCN HEALTH has published 11 studies in 2021 assessing the incidence and cost of illness of different diseases in Spain

The biopharmaceutical company, based at the BIC Bizkaia bioincubator, is also supplying its investigational biological drug MBK-01 under compassionate use

The upcoming edition of this event will be held on 28 April in Madrid, with over 300 participants and 50 investors from all over Europe

For World Health Day, we spoke with our members about the transversal nature of biotechnology and how work from one area can be applied in others, boosting animal, human and planet health

Peaches Biotech publishes in Biomolecules its work on how the immune system communicates with tissues that have been damaged or attacked by viruses or bacteria The Peaches Biotech drug belongs to a

Safety reporting is a crucial aspect of a successful clinical investigation for medical devices. Which are required to comply with the Medical Devices Regulation (EU) 2017/745 (MDR) and follow the

The Barcelona Science Park (PCB), in 2021 and the first two months of 2022, attracted 25 companies, consolidating its place among the most important hubs in Europe in the life sciences and healthcare

The incorporation comes in as the company launches important trials in the area of immunological oncology and regenerative tissue immunology.

The study will evaluate the safety and efficacy of ApTOLL in 30 patients with COVID-19 at four Spanish hospitals

Los fármacos donados desde 2007 han llegado a más de 600 millones niños de África subsahariana

In 2019 Immunostep R&D team recognized the great potential of these small extracellular vesicles and since then they have been working on the development of a line of products for research

The funds will be used to fuel pre-clinical trials for 5 different types of cancer